Corrigendum: Dawn of chimeric antigen receptor T cell therapy in non-Hodgkin Lymphoma

Abstract

The above paper¹ was published in Volume 1 Issue 3 of Advances in Cell and Gene Therapy. The authors have identified an error in the Introduction which they would like to amend.

In the final paragraph of page 1, the first sentence “The most common toxicity of CAR therapy is Cytokine Release….” should read “The most common toxicity of CAR therapy is Cytokine Release Syndrome (CRS),^8,19,20 which manifests on a spectrum from mild fever to severe multi-organ dysfunction requiring intensive care.”

The authors apologize for the error.